Corticosteroids for community-acquired pneumonia: a critical view of the evidence

Affiliations

Free article

Editorial

James D Chalmers. Eur Respir J. 2016 Oct.

Free article

. 2016 Oct;48(4):984-986.

doi: 10.1183/13993003.01329-2016.

¹ Scottish Centre for Respiratory Research, University of Dundee, Dundee, UK j.chalmers@dundee.ac.uk.

No abstract available

Comment on

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.
Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, Niederman MS, Agustí C. Torres A, et al. JAMA. 2015 Feb 17;313(7):677-86. doi: 10.1001/jama.2015.88. JAMA. 2015. PMID: 25688779 Clinical Trial.
Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia.
Wirz SA, Blum CA, Schuetz P, Albrich WC, Noppen C, Mueller B, Christ-Crain M, Tarr PE; STEP Study Group. Wirz SA, et al. Eur Respir J. 2016 Oct;48(4):1150-1159. doi: 10.1183/13993003.00474-2016. Epub 2016 Jul 28. Eur Respir J. 2016. PMID: 27471201 Clinical Trial.